ADAPTIVE BIOTECHNOLOGIES CORPORATION Basic Shares Outstanding (Weighted Average)
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Basic Shares Outstanding (Weighted Average) of 159.86 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 159.86M shares, a 5.11% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 155.52M shares, a 4.24% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 153.14M shares, a 3.70% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 152.43M shares, a 3.33% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for fiscal 2025 was 151.72M shares, a 3.14% increase from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for fiscal 2024 was 147.10M shares, a 1.88% increase from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for fiscal 2023 was 144.38M shares, a 1.31% increase from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION weighted average number of shares outstanding, basic for fiscal 2022 was 142.52M shares, a 1.54% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 159.86M shares 10-Q · filed 2026-08-04 | 157.70M shares 10-Q · filed 2026-08-04 | 156.17M shares derived: average of 3 quarters · filed 2026-08-04 | 155.24M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 155.52M shares 10-Q · filed 2026-05-05 | 154.33M shares derived: average of 2 quarters · filed 2026-05-05 | 153.70M shares derived: average of 3 quarters · filed 2026-05-05 | 153.29M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 153.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 152.79M shares derived: average of 2 quarters · filed 2026-02-26 | 152.55M shares derived: average of 3 quarters · filed 2026-08-04 | 151.72M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 152.43M shares 10-Q · filed 2025-11-05 | 152.26M shares derived: average of 2 quarters · filed 2026-08-04 | 151.25M shares 10-Q · filed 2025-11-05 | 150.35M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 152.08M shares 10-Q · filed 2026-08-04 | 150.65M shares 10-Q · filed 2026-08-04 | 149.65M shares derived: average of 3 quarters · filed 2026-08-04 | 149.12M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 149.20M shares 10-Q · filed 2026-05-05 | 148.44M shares derived: average of 2 quarters · filed 2026-05-05 | 148.13M shares derived: average of 3 quarters · filed 2026-05-05 | 147.95M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 147.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 147.60M shares derived: average of 2 quarters · filed 2026-02-26 | 147.54M shares derived: average of 3 quarters · filed 2026-02-26 | 147.10M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 147.52M shares 10-Q · filed 2025-11-05 | 147.47M shares derived: average of 2 quarters · filed 2025-11-05 | 146.91M shares 10-Q · filed 2025-11-05 | 146.41M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 147.41M shares 10-Q · filed 2025-08-05 | 146.60M shares 10-Q · filed 2025-08-05 | 146.04M shares derived: average of 3 quarters · filed 2026-02-26 | 145.70M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 145.79M shares 10-Q · filed 2025-05-01 | 145.35M shares derived: average of 2 quarters · filed 2026-02-26 | 145.13M shares derived: average of 3 quarters · filed 2026-02-26 | 144.95M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 144.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 144.81M shares derived: average of 2 quarters · filed 2026-02-26 | 144.67M shares derived: average of 3 quarters · filed 2026-02-26 | 144.38M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 144.70M shares 10-Q · filed 2024-11-07 | 144.55M shares derived: average of 2 quarters · filed 2024-11-07 | 144.21M shares 10-Q · filed 2024-11-07 | 143.92M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 144.40M shares 10-Q · filed 2024-08-01 | 143.96M shares 10-Q · filed 2024-08-01 | 143.66M shares derived: average of 3 quarters · filed 2025-03-03 | 143.47M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 143.51M shares 10-Q · filed 2024-05-07 | 143.29M shares derived: average of 2 quarters · filed 2025-03-03 | 143.17M shares derived: average of 3 quarters · filed 2025-03-03 | 142.97M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | 143.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 142.99M shares derived: average of 2 quarters · filed 2025-03-03 | 142.78M shares derived: average of 3 quarters · filed 2025-03-03 | 142.52M shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 142.93M shares 10-Q · filed 2023-11-09 | 142.65M shares derived: average of 2 quarters · filed 2023-11-09 | 142.33M shares 10-Q · filed 2023-11-09 | 142.06M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 142.36M shares 10-Q · filed 2023-08-02 | 142.03M shares 10-Q · filed 2023-08-02 | 141.77M shares derived: average of 3 quarters · filed 2024-02-29 | 141.53M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 141.70M shares 10-Q · filed 2023-05-03 | 141.47M shares derived: average of 2 quarters · filed 2024-02-29 | 141.26M shares derived: average of 3 quarters · filed 2024-02-29 | 141.03M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 141.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 141.04M shares derived: average of 2 quarters · filed 2024-02-29 | 140.81M shares derived: average of 3 quarters · filed 2024-02-29 | 140.35M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 140.83M shares 10-Q · filed 2022-11-03 | 140.60M shares derived: average of 2 quarters · filed 2022-11-03 | 140.06M shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 140.36M shares 10-Q · filed 2022-08-03 | 139.67M shares 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | 131.22M shares 10-K · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |